Compile Data Set for Download or QSAR
Report error Found 335 of affinity data for UniProtKB/TrEMBL: Q9UEE5
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM4814(SUNITINIB MALATE | CHEMBL535 | N-[2-(diethylamino)...)
Affinity DataKd:  1nMAssay Description:Binding affinity to DRAK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2011
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM4814(SUNITINIB MALATE | CHEMBL535 | N-[2-(diethylamino)...)
Affinity DataKd:  1nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM4814(SUNITINIB MALATE | CHEMBL535 | N-[2-(diethylamino)...)
Affinity DataKd:  1nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2011
Entry Details
PCBioAssay
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM4814(SUNITINIB MALATE | CHEMBL535 | N-[2-(diethylamino)...)
Affinity DataKd:  1nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/25/2012
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50355496(CHEMBL1908397)
Affinity DataKd:  2.90nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 3.30nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50308060(CEP-701 | 16-hydroxy-16-(hydroxymethyl)-15-methyl-...)
Affinity DataKd:  3.40nMAssay Description:Binding affinity to DRAK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2011
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50308060(CEP-701 | 16-hydroxy-16-(hydroxymethyl)-15-methyl-...)
Affinity DataKd:  3.40nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50585203(CHEMBL5085430)
Affinity DataIC50: 4.5nMAssay Description:Displacement of tracer K9 from NLuc fused DRAK1 (unknown origin) expressed in HEK293 cells by NanoBRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50024284(CHEMBL3334979)
Affinity DataKd:  4.90nMAssay Description:Binding affinity to DRAK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2016
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50520142(CHEMBL4435393)
Affinity DataKd:  5nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50520168(CHEMBL4549459 | US10894784, Example 16.01.02)
Affinity DataKd:  9nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50606011(CHEMBL5191892)
Affinity DataKd:  9nMAssay Description:Binding affinity to human N-terminal His-tagged/ TEV cleavage fused DRAK1 (39 to 369 residues) expressed in Escherichia coli by isothermal titration ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50274640(CHEMBL4126445)
Affinity DataIC50: 10nMAssay Description:Inhibition of recombinant human full length GST-tagged DRAK1 expressed in baculovirus expression systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/13/2020
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50520174(CHEMBL4553949 | US10894784, Example 16.06.02.A)
Affinity DataKd:  10nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441855(US10647686, Example (3))
Affinity DataIC50: 11nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642045(CHEMBL5573038)
Affinity DataIC50: 12nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50166076(CHEMBL3799585)
Affinity DataIC50: 12nMAssay Description:Inhibition of DRAK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50154342(CHEMBL3774448)
Affinity DataIC50: 13nMAssay Description:Inhibition of STK17A (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/6/2017
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50024285(CHEMBL3334980)
Affinity DataKd:  13nMAssay Description:Binding affinity to DRAK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2016
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50637406(CHEMBL4744680)
Affinity DataIC50: 14nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataKd:  14nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/19/2012
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataKd:  14nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/25/2012
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441866(US10647686, Example (13))
Affinity DataIC50: 14nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM31096(CHEMBL290084 | Staurosporine | cid_451705 | US2024...)
Affinity DataKd:  14nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2011
Entry Details
PCBioAssay
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50606011(CHEMBL5191892)
Affinity DataIC50: 15nMAssay Description:Inhibition of human N-terminal His-tagged/ TEV cleavage fused DRAK1 (39 to 369 residues) expressed in Escherichia coli using KKLNRTLSFAEPG peptide as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441876(US10647686, Example (23))
Affinity DataIC50: 15nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50520157(CHEMBL4436188)
Affinity DataIC50: 15nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441873(US10647686, Example (20))
Affinity DataIC50: 16nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642052(CHEMBL5579785)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642034(CHEMBL5574990)
Affinity DataIC50: 18nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441882(US10647686, Example (26))
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441862(US10647686, Example (9))
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441878(US10647686, Example (24))
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642049(CHEMBL5564156)
Affinity DataIC50: 19nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642041(CHEMBL5569603)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642048(CHEMBL5569176)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642047(CHEMBL5571334)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50166251(CHEMBL3799389)
Affinity DataIC50: 21nMAssay Description:Inhibition of DRAK1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50606012(CHEMBL5087558)
Affinity DataKd:  21nMAssay Description:Binding affinity to human N-terminal His-tagged/ TEV cleavage fused DRAK1 (39 to 369 residues) expressed in Escherichia coli by isothermal titration ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM4814(SUNITINIB MALATE | CHEMBL535 | N-[2-(diethylamino)...)
Affinity DataKd:  21nMAssay Description:Inhibition of STK17aMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2012
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM4814(SUNITINIB MALATE | CHEMBL535 | N-[2-(diethylamino)...)
Affinity DataKd:  21nMAssay Description:Average Binding Constant for STK17A; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441874(US10647686, Example (21))
Affinity DataIC50: 21nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642050(CHEMBL5575519)
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441881(US10647686, Example (25))
Affinity DataIC50: 22nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441870(US10647686, Example (17))
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441872(US10647686, Example 19 | US10647686, Example (19))
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataKd:  23nMAssay Description:Average Binding Constant for STK17A; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM441872(US10647686, Example 19 | US10647686, Example (19))
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/25/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 17A(Human)
Ambit Biosciences

Curated by ChEMBL
LigandPNGBDBM50642042(CHEMBL5575113)
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
Displayed 1 to 50 (of 335 total ) | Next | Last >>
Jump to: